Page 184 - RTCOG Annual Meeting 2021

14. Walsh CS. Two decades beyond BRCA1/2: Homologous recombination, hereditary
cancer risk and a target for ovarian cancer therapy. Gynecol Oncol. 2015;137:343-50.

15. National Cancer Institute. Surveillance, Epidemiology, and End Results Program. Cancer

Stat Facts: Female breast cancer [Internet]. [cited 2021 April 12]. Available from:
https://seer.cancer.gov/statfacts/html/breast.html.

16. Kuchenbaecker KB, Hopper JL, Barnes DR, Phillips KA, Mooij TM, Roos-Blom MJ, et al.

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
JAMA. 2017;317:2402-16.

17. Stewart SL, Wike JM, Foster SL, Michaud F. The incidence of primary fallopian tube

cancer in the United States. Gynecol Oncol. 2007;107:392-7.
18. Levine DA, Argenta PA, Yee CJ, Marshall DS, Olvera N, Bogomolniy F, et al. Fallopian

tube and primary peritoneal carcinomas associated with BRCA mutations. J Clin Oncol.

2003;21:4222-7.
19. Lu HM, Li S, Black MH, Lee S, Hoiness R, Wu S, et al. Association of Breast and Ovarian

Cancers With Predisposition Genes Identified by Large-Scale Sequencing. JAMA Oncol. 2019;5:51-7.

20. National Comprehensive Cancer Network. NCCN Clincial Practice Guidelines in
Oncology. Genetic/Familial High-Risk Assessment: Breast, Ovarian and Pancreastic. Version 1.2020

[Internet]. 2020 [cited 2020 June 20]. Available from:

https://www.nccn.org/professionals/physician_gls/pdf/genetics_bop.pdf
21. Lancaster JM, Powell CB, Chen LM, Richardson DL. Society of Gynecologic Oncology

statement on risk assessment for inherited gynecologic cancer predispositions. Gynecol Oncol.

2015;136:3-7.
22. Konstantinopoulos PA, Norquist B, Lacchetti C, Armstrong D, Grisham RN, Goodfellow

PJ, et al. Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO Guideline. J Clin

Oncol. 2020;38:1222-45.
23. Ledermann JA, Drew Y, Kristeleit RS. Homologous recombination deficiency and

ovarian cancer. Eur J Cancer. 2016;60:49-58.

24. Manchana T, Kobwitaya K. Survival Outcomes for Different Subtypes of Epithelial
Ovarian Cancer. Clin Res Obstetr Gynecol. 2018;1:1-7.

Genetic related gynecologic disorders and genetic testing 167